Bon Voyage, Muath.

On the 28 th of February, we had Muath's farewell party at Dr. Amin's house. Muath's research was on the DNA binding studies. He will be going back to Palestine on the 1st of March. Hope everything goes well . He will further his studies soon, InsyaAllah in the land of Hubert de Givenchy, Yves Saint Laurent, and Christian Louboutin. Hopefully insyaAllah. May Allah bless you in whatever you do, in your studies, in your career, and in your life.

We will miss you and all the best from all of us, EMAN laboratories.

PECIPTA 2009 : SILVER MEDAL

CONGRATULATIONS !!!

CONGRATULATIONS to Dr. Amin Malik Shah Abdul Majid, Hayder B. Sahib, Prof. Zahri Ismail, Dr. Salizawati M. Salhimi, Dr. Zaini Asmawi, M. Jamshed Siddiqui, and Khalid Hussin. Of course, not forgetting, Abdalrahim F.A. Aisha, Saleh Mustafa Al-Omari, and Norshirin Idris. 

The team won silver for product , Canssufive which is an inhibitor of angiogenesis and enhancer of Tamoxifen activity.

PECIPTA 2009 was held at KLCC on 8-10 October 2009 and was organized by Universiti Malaya. It was an annual  high profile Malaysia research exhibition where participants come from institutions of higher learning inside and outside of Malaysia.

PRESS CONFERENCE : CANSSUFIVE

The press conference was held on  21 October 2009, Wednesday at 11 am at Level 6 Canselory Building at the Universiti Sains Malaysia, Penang Campus.

 

EMAN group of researchers  has succeeded in producing standardised “Misai Kucing” (Orthosiphon Stamineus) herbal extract for the treatment of cancer.This novel  herbal extract is presented in the form of a pill is called CANSSUFIVE. Our group, headed by Dr. Amin Malik Shah has found out that Misai Kucing (literally meaning, Cat”s Whiskers), has high anti-oxidant content that could prevent and control the growth of cancer cells. 

“CANSSUFIVE shows very promising results in breast cancer treatment when given together with chemotherapy,”- Dr. Amin Malik Shah bin Abdul Majid

Dr. Amin said, the Misai Kucing extract named “CANSSUFIVE” was tested on animals and found to retard blood vessel development, thus preventing the cancel cells from spreading to tissues and other organs. He also planned to do clinical study on the effectiveness of Canssufive on humans as soon as possible so that cancer patients and others can get it on the market.

BIOREACTOR TRAINING

On 6th and 7th of August 2009, a workshop on Bioreactor Operation was held in Physiology Teaching Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia. The workshop was organized by Pharmacology and Physiology Department, School of Pharmaceutical Sciences; USM in collaboration with Intran Technologies Sdn. Bhd. Intran Technologies Sdn. Bhd. is the company who supplied and maintained the bioreactor unit owned by the school.

15 participants whom were postgraduate students from School of Pharmaceutical Sciences, School of Biological Sciences, INFORMM and also Malaysian Institute of Pharmaceuticals and Nutraceuticals (iPHARM) participated in the two days workshop. In addition, there were 5 staffs from Intran Technologies Sdn. Bhd., who joined the workshop. The facilitator of the workshop was Mr. Mohd Rizal, a bioprocess expert from Universiti Putra Malaysia.

The workshop conducted involved lectures of theories and explanation regarding the bioreactor unit and components and their respective functions. The facilitator also conducted the workshop in laboratory session, to give deeper explanation about the bioreactor unit and its components to the participants, so as to increase participants’ understanding regarding the theories given in lectures. The facilitator did also show the basic operation of the bioreactor unit during the laboratory session. The bioreactor unit used in this workshop was of 3L working capacity. The bioreactor unit used as the model for this workshop is the unit which is currently located in Immunopharmacology Laboratory (J02-119).

-written by Syima-